antibiotics (Summit Therapeutics/Roche)

N/A

Report date: 2025/01/26 19:32:07
NME

Base Information

Drug Nameantibiotics (Summit Therapeutics/Roche)
Drug Alias Nameantibiotics (Discuva/Roche)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDiscuva Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding LtdSummit Therapeutics Plc
Inactive CompaniesDiscuva Ltd
Active IndicationsMultidrug-Resistant InfectionGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A